Literature DB >> 12691779

The novel dopamine D4 receptor agonist (PD 168,077 maleate): doses with different effects on locomotor activity are without effect in classical conditioning.

Sahana Nayak1, Helen J Cassaday.   

Abstract

Conditioning is normally selective to the most likely predictors of motivationally significant events and some dopamine (DA) agonists produce dysfunction in this process. Moreover, the DA D(4) receptor is implicated in normal and abnormal functions that have some dopaminergic basis (e.g., in attention deficit hyperactivity disorder and schizophrenia). We therefore used locomotor activity to identify doses of a novel D(4) receptor agonist (PD 168,077) with contrasting behavioral effects (over the range 0.064-1 mg/kg). Doses that either did (0.064 mg/kg) or did not (0.5 mg/kg) significantly increase activity were then tested using aversive and appetitive procedures, in which conditioning was reflected in decreased and increased response rates, respectively. Associating a signal with food or foot shock is normally reduced in trace conditioning, when stimulus events are separated in time. Similarly, animals normally learn relatively little about background stimuli that do not well predict food delivery or the onset of shock. Both doses of PD 168,077 were without effect on conditioning, whether appetitive or aversive, and irrespective of how informative the predictive stimulus was. Thus, we find no evidence that the D(4) receptor has any likely effect on associative learning or its disorder. Furthermore, D(4)-mediated hyperactivity was dissociable from cognitive effects.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12691779     DOI: 10.1016/S0278-5846(03)00031-9

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  8 in total

1.  Blockade of dopamine d4 receptors attenuates reinstatement of extinguished nicotine-seeking behavior in rats.

Authors:  Yijin Yan; Abhiram Pushparaj; Yann Le Strat; Islam Gamaleddin; Chanel Barnes; Zuzana Justinova; Steven R Goldberg; Bernard Le Foll
Journal:  Neuropsychopharmacology       Date:  2011-10-26       Impact factor: 7.853

2.  Synthesis and evaluation of ligands for D2-like receptors: the role of common pharmacophoric groups.

Authors:  Donald M N Sikazwe; Nancy T Nkansah; Ramazan Altundas; Xue Y Zhu; Bryan L Roth; Vincent Setola; Seth Y Ablordeppey
Journal:  Bioorg Med Chem       Date:  2008-12-31       Impact factor: 3.641

3.  Ro 04-6790-induced cognitive enhancement: no effect in trace conditioning and novel object recognition procedures in adult male Wistar rats.

Authors:  K E Thur; A J D Nelson; H J Cassaday
Journal:  Pharmacol Biochem Behav       Date:  2014-10-24       Impact factor: 3.533

4.  Neuronal correlates of ketamine and walking induced gamma oscillations in the medial prefrontal cortex and mediodorsal thalamus.

Authors:  Katrina E Furth; Alex J McCoy; Caroline Dodge; Judith R Walters; Andres Buonanno; Claire Delaville
Journal:  PLoS One       Date:  2017-11-02       Impact factor: 3.240

Review 5.  Attention-deficit/hyperactive disorder updates.

Authors:  Miriam Kessi; Haolin Duan; Juan Xiong; Baiyu Chen; Fang He; Lifen Yang; Yanli Ma; Olumuyiwa A Bamgbade; Jing Peng; Fei Yin
Journal:  Front Mol Neurosci       Date:  2022-09-21       Impact factor: 6.261

6.  Dopamine, cognitive function, and gamma oscillations: role of D4 receptors.

Authors:  Katrina E Furth; Surjeet Mastwal; Kuan H Wang; Andres Buonanno; Detlef Vullhorst
Journal:  Front Cell Neurosci       Date:  2013-07-02       Impact factor: 5.505

7.  Noradrenergic versus dopaminergic modulation of impulsivity, attention and monitoring behaviour in rats performing the stop-signal task: possible relevance to ADHD.

Authors:  A Bari; T W Robbins
Journal:  Psychopharmacology (Berl)       Date:  2013-05-17       Impact factor: 4.530

8.  The dopamine D1 receptor agonist SKF81297 has dose-related effects on locomotor activity but is without effect in a CER trace conditioning procedure conducted with two versus four trials.

Authors:  M A Pezze; H J Marshall; H J Cassaday
Journal:  Learn Motiv       Date:  2016-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.